Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Interest & Investment Income: 2021-2024

Historic Interest & Investment Income for Immunocore Holdings (IMCR) over the last 4 years, with Dec 2024 value amounting to $25.6 million.

  • Immunocore Holdings' Interest & Investment Income fell 30.82% to $4.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.7 million, marking a year-over-year decrease of 31.45%. This contributed to the annual value of $25.6 million for FY2024, which is 42.43% up from last year.
  • Per Immunocore Holdings' latest filing, its Interest & Investment Income stood at $25.6 million for FY2024, which was up 42.43% from $18.0 million recorded in FY2023.
  • In the past 5 years, Immunocore Holdings' Interest & Investment Income registered a high of $25.6 million during FY2024, and its lowest value of $65,000 during FY2021.
  • In the last 3 years, Immunocore Holdings' Interest & Investment Income had a median value of $18.0 million in 2023 and averaged $15.8 million.
  • Data for Immunocore Holdings' Interest & Investment Income shows a peak YoY skyrocketed of 5,678.46% (in 2022) over the last 5 years.
  • Immunocore Holdings' Interest & Investment Income (Yearly) stood at $65,000 in 2021, then soared by 5,678.46% to $3.8 million in 2022, then soared by 378.86% to $18.0 million in 2023, then skyrocketed by 42.43% to $25.6 million in 2024.